S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
NASDAQ:NOVN

Novan Stock Forecast, Price & News

$3.79
+0.04 (+1.07%)
(As of 01/14/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.60
$3.95
50-Day Range
$3.75
$7.09
52-Week Range
$3.60
$25.90
Volume
207,199 shs
Average Volume
159,810 shs
Market Capitalization
$71.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.06
30 days | 90 days | 365 days | Advanced Chart
Receive NOVN News and Ratings via Email

Sign-up to receive the latest news and ratings for Novan and its competitors with MarketBeat's FREE daily newsletter.


Novan logo

About Novan

Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NOVN
Employees
23
Year Founded
N/A

Sales & Book Value

Annual Sales
$4.92 million
Book Value
$0.21 per share

Profitability

Net Income
$-29.29 million
Net Margins
-833.16%
Pretax Margin
-833.16%

Debt

Price-To-Earnings

Miscellaneous

Free Float
18,496,000
Market Cap
$71.31 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/10/2021
Today
1/17/2022
Next Earnings (Estimated)
2/24/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.53 out of 5 stars

Medical Sector

1071st out of 1,417 stocks

Pharmaceutical Preparations Industry

519th out of 683 stocks

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Novan (NASDAQ:NOVN) Frequently Asked Questions

Is Novan a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Novan in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Novan stock.
View analyst ratings for Novan
or view top-rated stocks.

When is Novan's next earnings date?

Novan is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for Novan
.

How were Novan's earnings last quarter?

Novan, Inc. (NASDAQ:NOVN) issued its earnings results on Wednesday, November, 10th. The company reported ($0.34) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.42) by $0.08. The business earned $0.74 million during the quarter, compared to analyst estimates of $0.74 million. Novan had a negative net margin of 833.16% and a negative trailing twelve-month return on equity of 179.38%. During the same period in the previous year, the business earned ($0.60) EPS.
View Novan's earnings history
.

What price target have analysts set for NOVN?

4 brokers have issued 12 month price targets for Novan's stock. Their forecasts range from $2.00 to $16.00. On average, they expect Novan's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 84.7% from the stock's current price.
View analysts' price targets for Novan
or view top-rated stocks among Wall Street analysts.

Who are Novan's key executives?

Novan's management team includes the following people:
  • Paula Brown Stafford, Chairman, President & Chief Executive Officer
  • John M. Gay, Chief Financial Officer, Secretary & VP
  • Carri Geer, Chief Technology Officer & Senior Vice President
  • Tomoko Maeda-Chubachi, Chief Medical Officer
  • Elizabeth Messersmith, Chief Development Officer & Senior Vice President

What other stocks do shareholders of Novan own?

When did Novan IPO?

(NOVN) raised $46 million in an IPO on Wednesday, September 21st 2016. The company issued 3,800,000 shares at $11.00-$13.00 per share. Piper Jaffray acted as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

What is Novan's stock symbol?

Novan trades on the NASDAQ under the ticker symbol "NOVN."

How do I buy shares of Novan?

Shares of NOVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novan's stock price today?

One share of NOVN stock can currently be purchased for approximately $3.79.

How much money does Novan make?

Novan has a market capitalization of $71.31 million and generates $4.92 million in revenue each year. The company earns $-29.29 million in net income (profit) each year or ($2.03) on an earnings per share basis.

How many employees does Novan have?

Novan employs 23 workers across the globe.

What is Novan's official website?

The official website for Novan is www.novan.com.

Where are Novan's headquarters?

Novan is headquartered at 4105 HOPSON ROAD, MORRISVILLE NC, 27560.

How can I contact Novan?

Novan's mailing address is 4105 HOPSON ROAD, MORRISVILLE NC, 27560. The company can be reached via phone at (919) 485-8080, via email at [email protected], or via fax at 919-237-9212.


This page was last updated on 1/17/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.